Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor

WANG WenHui; DUAN XuHua; LI Hao; LI FengYao; JU ShuGuang; WANG ManZhou; REN JianZhuang; HAN XinWei

doi:10.3969/j.issn.1001-5256.2020.12.018

Volume 36 Issue 12

Dec. 2020

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2020 > 36(12): 2730-2734

PDF( 1057 KB)

Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor

DOI: 10.3969/j.issn.1001-5256.2020.12.018

Department of Interventional Radiology,The First Affiliated Hospital of Zhengzhou University

Research funding:

Received Date: 2020-06-15
Published Date: 2020-12-20

Abstract

Abstract

Objective To investigate the effect of arsenic trioxide-loaded CalliSpheres beads( CBATO) in transarterial chemoembolization( TACE) in the treatment of rabbits with VX2 liver tumor. Methods A total of 120 tumor-bearing rabbits were divided into control group,CalliSpheres beads( CB) group( blank beads for TACE),CBATO group,and conventional TACE( cTACE) group( arsenic trioxide lipiodol for TACE) using a random number table,with 30 rabbits in each group. Five rabbits in each group were sacrificed at 12 hours and on days 3,7,and 14 after TACE,and immunohistochemistry was used to measure the proliferation index and apoptosis percentage of tumor cells in the residual tumor area. The tumor necrotic volume was measure on day 7 after TACE,and the growth rate and necrosis rate of tumor cells were calculated. Ten rabbits were randomly selected from each group for the observation of survival time. An analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups; the Kaplan-Meier survival analysis was used to evaluate survival time,and the log-rank test was used for comparison.Results On day 7 after TACE,the CBATO group had a significantly lower growth rate and a significantly higher necrosis rate of tumor cells than the cTACE group,the CB group,and the control group( all P < 0. 05). At each time point after TACE,there were significant differences in the proliferation index and apoptosis percentage of tumor cells between the CBATO group and the other three groups( all P < 0. 05).The median survival time was 26 days in the CBATO group,18. 5 days in the CB group,22 days in the cTACE group,and 15. 5 days in the control group,and the CBATO group had a significantly longer survival time than the other three groups( χ2= 3. 95,8. 99,and 13. 47,P =0. 049,P = 0. 003,and P < 0. 01). Conclusion CBATO has a better effect than cTACE and CB in the treatment of rabbits with VX2 liver tumor and can significantly improve tumor necrosis rate,promote the apoptosis of tumor cells,and prolong the survival time of experimental animals.
- liver neoplasms,
- drug-eluting beads,
- arsenic trioxide,
- disease models,animal

FullText(HTML)

References(17)

References

[1] FORNER A,GILABERT M,BRUIX J,et al. Treatment of intermediate-stage hepatocellular carcinoma[J]. Nat Rev Clin Oncol,2014,11(9):525-535.

[2] ZHAO GR,LI H,DUAN XH,et al. The loading,releasing and antitumor mechanism of arsenic trioxide loaded by Calli Spheresbeads[J]. Chin J Radiol,2019,53(8):737-741.(in Chinese)赵国瑞，李浩，段旭华，等．Calli Spheres载药栓塞微球对三氧化二砷的加载释放及抗肿瘤机制研究[J]．中华放射学杂志，2019,53(8):737-741.

[3] MALAGARI K,POMONI M,MOSCHOURIS H,et al. Chemoemboliz tion of hepatocellular carcinoma with hepasphere 30-60μm. safety and efficacy study[J]. Cardiovasc Intervent Radiol,2014,37(1):165-175.

[4] XING M,WEBBER G,PRAJAPATI HJ,et al. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma:Longitudinal prospective study[J]. J Gastroenterol Hepatol,2015,30(7):1167-1174.

[5] LI H,DUAN XH,HAN XW,et al. Pharmacokinetics of drugeluting beads loading arsenic trioxide in the treatment of rabbit VX2 liver tumour[J]. Chin J Radiol,2019,53(7):615-620.(in Chinese)李浩，段旭华，韩新巍，等．载药微球三氧化二砷治疗兔VX2肝肿瘤药代动力学研究[J]．中华放射学杂志，2019,53(7):615-620.

[6] DUAN XH,LI TF,ZHOU GF,et al. Transcatheter arterial embolization combined with radiofrequency ablation activates CD8(+)T-cell infiltration surrounding residual tumors in the rabbit VX2 liver tumors[J]. Onco Targets Ther,2016,9:2835-2844.

[7] DUAN XH,LI H,REN JZ,et al. Hepatic arterial chemoembolization with arsenic trioxide eluting callispheres microspheres versus lipiodol emulsion:Pharmacokinetics and intratumoral concentration in a rabbit liver tumor model[J]. Cancer Manag Res,2019,11:9979-9988.

[8] PESAPANE F,NEZAMI N,PATELLA F,et al. New concepts in embolotherapy of HCC[J]. Med Oncol,2017,34(4):58.

[9] SONG MJ,CHUN HJ,SONG DS,et al. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma[J]. J Hepatol,2012,57(6):1244-1250.

[10] YIN WL,LIAN J,XIAO SX,et al. Clinical effect of drug-eluting beads and conventional transcatheter arterial chemoembolization in treatment of unresectable liver cancer:A metaanalysis[J]. J Clin Hepatol,2019,35(6):1270-1275.(in Chinese)尹伟利，连佳，肖时湘，等．载药微球与传统碘化油经肝动脉化疗栓塞术治疗不可切除肝癌效果比较的Meta分析[J]．临床肝胆病杂志，2019,35(6):1270-1275.

[11] HONG K,KHWAJA A,LIAPI E,et al. New intra-arterial drug delivery system for the treatment of liver cancer:Preclinical assessment in a rabbit model of liver cancer[J]. Clin Cancer Res,2006,12(8):2563-2567.

[12] DUAN XH,JU SG,HAN XW,et al. Arsenic trioxide-eluting Callispheres beads is more effective and equally tolerant compared with arsenic trioxide/lipiodol emulsion in the transcatheter arterial chemoembolization treatment for unresectable hepatocellular carcinoma patients[J]. Eur Rev Med Pharmacol Sci,2020,24(3):1468-1480.

[13] LIU B,HUANG JW,LI Y,et al. Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis:A single-blind,randomized trial[J]. J Cancer Res Clin Oncol,2015,141(6):1103-1108.

[14] KIMURA H,WEISZ A,KURASHIMA Y,et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide:Control of hypoxia-inducible factor-1 activity by nitric oxide[J]. Blood,2000,95(1):189-197.

[15] TINGTING R,WEI G,CHANGLIANG P,et al. Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway[J]. Cancer Biol Ther,2010,10(3):251-257.

[16] LEW YS,BROWN SL,GRIFFIN RJ,et al. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown[J]. Cancer Res,1999,59(24):6033-6037.

[17] VIVEIROS P,RIAZ A,LEWANDOWSKI RJ,et al. Current state of liver-directed therapies and combinatory approaches with systemic therapy in hepatocellular carcinoma(HCC)[J].Cancers(Basel),2019,11(8):1085.

Relative Articles

[1]	Wenhui WANG, Xuhua DUAN, Hao LI, Shuguang JU, Manzhou WANG, Jianzhuang REN, Xinwei HAN. A cost-effect analysis of transarterial chemoembolization with CalliSpheres beads loaded with arsenic trioxide versus arsenic trioxide iodized oil emulsion in treatment of unresectable liver cancer[J]. Journal of Clinical Hepatology, 2021, 37(9): 2125-2129. doi: 10.3969/j.issn.1001-5256.2021.09.024
[2]	Du YiChao, Zhang Hao, Zhong FuRui, Cheng HuanLi, Lai Li, Qian BaoLin, Tan Peng, Xia XianMing, Fu WenGuang. Protective effect of pinocembrin in a mouse model of liver injury induced by acetaminophen[J]. Journal of Clinical Hepatology, 2020, 36(3): 608-611. doi: 10.3969/j.issn.1001-5256.2020.03.027
[3]	Ha FuShuang, Han Tao, Liang Ning, Nie XinHua, Zhu ZhengYan. Effect of recombinant human granulocyte colony-stimulating factor on rats with acute liver failure[J]. Journal of Clinical Hepatology, 2019, 35(7): 1565-1569. doi: 10.3969/j.issn.1001-5256.2019.07.028
[4]	Li ShanShan, Zhang Ke, Cheng ShuJie, Yang JiHong, Gao Feng, Li JingHua. Current status and future perspectives of the application of medical 3D visualization technology in accurate surgery of liver tumors[J]. Journal of Clinical Hepatology, 2019, 35(5): 1114-1117. doi: 10.3969/j.issn.1001-5256.2019.05.042
[5]	Zhang YongChao, Bi YanZhen, Fang Xiao, Wang QuanYi, Wang QuanQuan, Tang HuiXin, Kong LingBin, Chen Yu, Duan ZhongPing, Shu ZhenFeng, Hong Feng. Protective effect of probiotics in rats with acute-on-chronic liver failure and related mechanism[J]. Journal of Clinical Hepatology, 2019, 35(7): 1570-1575. doi: 10.3969/j.issn.1001-5256.2019.07.029
[6]	Wang Hao, He Cheng, Chen Hao, Ou YangZhongMin, Liu ZhiQiang. Value of Gd-EOB-DTPA-enhanced MRI in the assessment of liver function in dogs with acute liver failure[J]. Journal of Clinical Hepatology, 2019, 35(7): 1576-1581. doi: 10.3969/j.issn.1001-5256.2019.07.030
[7]	Zhou QiFeng, Zhang LingQiang, Liao MengJiao, Pang MingQuan, Li MengXuan, Ren Li, Fan HaiNing. Establishment of a subcutaneous xenograft tumor model of alveolar echinococcosis in nude mice[J]. Journal of Clinical Hepatology, 2018, 34(3): 588-590. doi: 10.3969/j.issn.1001-5256.2018.03.028
[8]	Ji JunSong, Chen Ting, Wang Hui, Wang ChenYi, Zhu XinYing, Yin Hao, Fu ZhiRen. Effect of arsenic trioxide chemotherapy on survival time in liver cancer patients undergoing liver transplantation[J]. Journal of Clinical Hepatology, 2017, 33(9): 1745-1748. doi: 10.3969/j.issn.1001-5256.2017.09.023
[9]	Li Dong, Lu ZhongHua, Gan JianHe. Establishment of a rat model of early-stage liver failure and Th17/Treg imbalance[J]. Journal of Clinical Hepatology, 2016, 32(5): 928-932. doi: 10.3969/j.issn.1001-5256.2016.05.025
[10]	Chen Jing, Liu XiaoYan, Yang HaoZhen, Huang Kun, Hu JinHua, Xin ShaoJie. Study on p-p38 expression and its significance in liver tissues of mice with acute liver failure and patients with HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2015, 31(4): 556-559. doi: 10.3969/j.issn.1001-5256.2015.04.019
[11]	Pang GuoJin, Chen ShuangJun, Zhao WeiHua, Liu TianHui, Wang Ping, You Hong, Cong Min. Dynamic change of hepcidin in liver fibrosis induced by CCl4 among mice[J]. Journal of Clinical Hepatology, 2015, 31(3): 418-423. doi: 10.3969/j.issn.1001-5256.2015.03.025
[12]	Gao ChengGuang, Chen RiXia. Clinical research on treatment of advanced primary liver cancer with combination of thymosin α1 and arsenic trioxide[J]. Journal of Clinical Hepatology, 2015, 31(4): 564-568. doi: 10.3969/j.issn.1001-5256.2015.04.021
[13]	Huang HaiYan, Xin YongNing, Jiang Man, Jin WenWen, Jiang XiangJun, Xuan ShiYing. Research advances in animal models of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2014, 30(9): 948-953. doi: 10.3969/j.issn.1001-5256.2014.09.028
[14]	Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001
[15]	Jiang Han, Wang XueFeng, Wang ZiHao, Xu Bin, Shi WeiBin. The establishment of rabbit VX2 hepatic tumor model and the application of nano-scale microbubble contrast agent in the diagnosis of this model[J]. Journal of Clinical Hepatology, 2011, 27(7): 746-748.
[16]	Sun LinLin, Shi Jun, Hao JingHua, Ren WanHua, Yan ChunYing, Zhang Jie, Lin XiaoYan, Cui Bin. Effect of high-fat diet on establishment of a rat non-alcoholic steatohepatitis/liver fibrosis model[J]. Journal of Clinical Hepatology, 2011, 27(3): 254-257+272.
[17]	Ye LiHong, Wang ChongKui, Tian YueYang, Xu Yi, Zheng HaoJie, Shao ShiXiang, Dai ErHei. Effect of Ruangan Huajian granule on hepatic expression of PDGF - B in C57 mice with experimental hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1047-1050.
[18]	Song Yu, Yu Zheng, Fan YanHua, Yao ShuKun, Wang TaiLing. A rat model of hepatic veno-occlusive disease induced by the Gynura root water decoction[J]. Journal of Clinical Hepatology, 2011, 27(8): 860-864.
[19]	Lou GuoHua, Liu YanNing, Yin ChunBen, Chen Feng, Jia ZhanSheng, Chen Zhi. Preliminary study of HCV mouse model induced by infectious HCV 2a plasmid[J]. Journal of Clinical Hepatology, 2011, 27(1): 72-75.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	任金瓶，袁坤山，张淑欣，史文广，张海军. 离子交换型载药栓塞微球研究进展. 中国介入影像与治疗学. 2022(07): 437-440 .
2.	卞晓山，王作志，宋智兴. 三氧化二砷经导管肝动脉化疗栓塞介入治疗中晚期原发性肝癌临床疗效及安全性观察. 临床和实验医学杂志. 2021(07): 705-708 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (4465) PDF downloads(76)

Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor

DOI: 10.3969/j.issn.1001-5256.2020.12.018